Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas
NCT04197492
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Malignant Glioma
Interventions
RADIATION:
Hypofractionated Stereotactic Radiotherapy
DRUG:
Anlotinib
Sponsor
Huashan Hospital